SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 37 filers reported holding SQZ BIOTECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $292,000 | -42.2% | 60,693 | +7.4% | 0.00% | – |
| Q4 2021 | $505,000 | -37.7% | 56,497 | +0.6% | 0.00% | – |
| Q3 2021 | $811,000 | -32.8% | 56,180 | -32.7% | 0.00% | – |
| Q2 2021 | $1,206,000 | +93.3% | 83,446 | +82.9% | 0.00% | – |
| Q1 2021 | $624,000 | -13.9% | 45,614 | +82.4% | 0.00% | – |
| Q4 2020 | $725,000 | – | 25,002 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 807,827 | $23,411,000 | 1.79% |
| Alphabet Inc. | 831,389 | $24,094,000 | 1.16% |
| Artal Group S.A. | 1,606,308 | $46,551,000 | 1.00% |
| 683 Capital Management, LLC | 466,176 | $13,510,000 | 0.64% |
| MAVERICK CAPITAL LTD | 935,971 | $27,124,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 2,513,924 | $72,854,000 | 0.31% |
| CAAS CAPITAL MANAGEMENT LP | 150,000 | $4,347,000 | 0.04% |
| HRT FINANCIAL LP | 17,456 | $505,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 11,660 | $350,000 | 0.01% |
| Hudock, Inc. | 350 | $10,000 | 0.00% |